Last update 24 May 2025

BEBT-503

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BEBT 503, BEBT-503, BEBT503
Target
PPARα
Action
agonists
Mechanism
PPARα agonists(Peroxisome proliferator-activated receptor α agonists)
Therapeutic Areas
Digestive System DisordersEndocrinology and Metabolic DiseaseOther Diseases
Active Indication
Diabetes Mellitus, Type 2Nonalcoholic SteatohepatitisPrimary Biliary Cholangitis
Inactive Indication-
Originator Organization
BeBetter Med, Inc.BeBetter Med, Inc.
Active Organization
BeBetter Med, Inc.BeBetter Med, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with BEBT-503
CTR20233235
/ RecruitingPhase 1
BEBT-503在中国健康受试者中单次递增剂量（SAD）和多次递增剂量（MAD）的安全性、耐受性和药代动力学的随机、双盲、安慰剂对照Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study of the safety, tolerability and pharmacokinetics of BEBT-503 in Chinese healthy subjects with single ascending dose (SAD) and multiple ascending dose (MAD)
NCT05391880
/ CompletedPhase 1
A Randomized, Double-Blind, Placebo-Controlled Study of Orally Administered BEBT-503 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (SAD) and Multiple Ascending Doses (MAD) in Healthy Subjects
100 Clinical Results associated with BEBT-503
Login to view more data
100 Translational Medicine associated with BEBT-503
Login to view more data
100 Patents (Medical) associated with BEBT-503
Login to view more data
100 Deals associated with BEBT-503
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 1
China
BeBetter Med, Inc.BeBetter Med, Inc.
28 Feb 2024
Nonalcoholic SteatohepatitisPhase 1
Australia
BeBetter Med, Inc.BeBetter Med, Inc.
01 Aug 2022
Primary Biliary CholangitisPhase 1
China
BeBetter Med, Inc.BeBetter Med, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free